Medtech contract research organization Factory-CRO Group is changing its name to Avania. Formed Boston-based Boston Biomedical Associates (Marlborough, Mass.), Factory CRO (Bilthoven, Netherlands), Five Corners (Artarmon, Australia), and MileStone Research Organization (San Diego), Avania said it will bring together regional teams of experts across a wide range of therapeutic specialties, including medical devices, novel technology, […]
Medpace (NSDQ:MEDP) yesterday said affiliates of Cinven Capital Management are launching a secondary offering of 4 million shares of its common stock at $31.50 per share, for gross proceeds of $126 million – not including an underwriter’s option worth another $18.9 million. The offering includes a 30-day underwriters option to purchase an additional 600,000 shares, Cincinnati-based […]
Contract research organization Medpace (NSDQ:MEDP) said yesterday that its initial public offering closed after raising more than $185 million, including an underwriter’s over-allotment that added more than $24 million to the IPO. Cincinnati-based Medpace said it floated 8.05 million shares at $23 apiece, including the 1.05-million-share over-allotment, netting about $173.6 million for the CRO. The proceeds are earmarked […]
Ximedica said today that SV Life Sciences picked up a majority interest in the Providence, R.I.-based medical device development company from co-founders Stephen Lane and Aidan Petrie for an undisclosed amount.
There’s a special sauce in the recipe Ora Inc. uses to run clinical trials for ophthalmology devices and drugs that can reduce the time needed for a study from 6 months to 2 days: The eye care practice started by Ora founder Dr. Mark Abelson.
An ophthalmologist and optometric scientist and fellow at the Mass. Eye & Ear Infirmary, Abelson founded Andover Eye in 1978, his son Stuart Abelson – now Andover, Mass.-based Ora’s CEO – told MassDevice.com.